Answers are grounded in this paper and cite their sources.
Background A developing literature suggests that transcranial magnetic stimulation (TMS) can target anhedonia and suicidal ideation (SI), core symptoms of treatment-resistant depression (TRD). This present naturalistic study extends the existing literature by investigating the connection between changes in anhedonia and suicidal ideation (SI) related to transcranial magnetic stimulation (TMS), independent of any overall changes in depression. Methods Pre and post treatment PHQ-9 and IDS-SR data were collected from 181 TRD patients who received dorsolateral prefrontal cortex ( dlPFC) TMS using the Figure-8 or H1-coil. Changes in overall depression symptoms, anhedonia, and SI were analyzed using chi square tests, repeated measure ANOVAS, and linear regression for repeated measures. Results TMS yielded changes in overall depression symptoms (PHQ-9 Cohen's d = 1.02; IDS-SR Cohen's d = 1.05), with 23.9 % and 41.7 % of patients experiencing response as measured by IDS-SR and PHQ-9, respectively. TMS treatment was also associated with large changes in both anhedonia ( d = 1.03) and SI ( d = 0.88), which were similar in magnitude to changes in all other depression symptoms ( d = 0.97). Importantly, changes in anhedonia predicted changes in SI, even after controlling for baseline depression severity and change in other depression symptoms. Limitations The lack of a control arm and a neuroimaging measure temper mechanistic conclusion. Conclusion Our results reinforce the effectiveness of TMS in TRD and provide new evidence that anhedonia and SI may belong to a broader symptom cluster potentially undergirded by a shared circuitry accessible to dlPFC TMS.
No takes yet. Share an insight, caveat, or question.
Sonmez et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: